We have observed
9 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES
PROCESS FOR PREPARING LACOSAMIDE
AUTOIMMUNE AND INFLAMMATORY DISORDER THERAPY
THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE DERIVATIVES
THERAPEUTICALLY ACTIVE OXAZOLINE DERIVATIVES
Purine analogues and their use as immunosuppressive agents
THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES
QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS
ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES